Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04188548 |
| Title | A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer (EMBER) |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Eli Lilly and Company |
| Indications | |
| Therapies |
Abemaciclib + LY3484356 + Trastuzumab Abemaciclib + Anastrozole + LY3484356 |
| Age Groups: | adult | senior |
| Covered Countries | USA | FRA | ESP | BEL |